Fresh Tracks Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Fresh Tracks Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q4 2023.
  • Fresh Tracks Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$49K -100% Dec 31, 2023 10-K 2024-03-15
Q3 2023 $0 -$15K -100% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $17K -$13K -43.3% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $25K -$20K -44.4% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $49K -$10K -16.9% Dec 31, 2022 10-K 2024-03-15
Q3 2022 $15K -$57K -79.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $30K -$56K -65.1% Jun 30, 2022 10-Q/A 2022-09-01
Q1 2022 $45K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $59K -$15K -20.3% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $72K -$22K -23.4% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $86K -$28K -24.6% Jun 30, 2021 10-Q 2021-08-12
Q4 2020 $74K -$85K -53.5% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $94K -$82K -46.6% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $114K Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $133K Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $159K Dec 31, 2019 10-K 2021-03-09
Q3 2019 $176K Sep 30, 2019 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.